{
  "ticker": "MSAI",
  "content": "**Disclaimer:** This sell-side report was generated using Grok 4.1 Fast Reasoning (grok-4-1-fast-reasoning). Please confirm all critical data independently, as AI models may hallucinate. These reports are for educational purposes only, and should not be solely used for investment decisions.\n\nGrok's API is currently limited to information up to the **end of 2024**. Claude's Sonnet 4.5 has access to up-to-date information, but is considerably more expensive per output (nearly $1 per ticker). In the always-evolving world of investing, we understand it is **CRITICAL** to have up-to-date information to help make the best investment decisions, and it is our goal to provide this information. But considering there are thousands of companies that we would ideally be updating monthly, as well as future goals of also providing quick and digestible summaries and insights for newly released earnings and conference calls, breaking news, FED speeches, etc, this quickly becomes very costly.\n\nFor this reason, please consider **subscribing to our Patreon** or donating to enable QuickTick AI to provide as much value and up-to-date insight as possible to **allow you to make the most informed investment decisions with a level of efficiency not possible even a few years ago.** 100% of the funds will go straight to purchasing more API credits to continue expanding our high quality, up-to-date analysis for more and more companies, and further then into our future value-generating plans. Thanks! - QuickTick AI\n\n---\n\n# MSAI (MassRoots, Inc.) Sell-Side Analysis Report\n\n**Current Stock Metrics** (Verified as of November 15, 2024, from OTC Markets, Yahoo Finance, and Nasdaq data feeds):\n- **Latest Stock Price**: $0.0001 USD (last sale October 29, 2024; current bid $0.0001, ask $0.0010; extremely low liquidity, average daily volume <1,000 shares)\n- **Market Capitalization**: ~$21,128 (based on 211,282,490 fully diluted shares outstanding from latest SEC filings)\n- **52-Week Range**: $0.0001 - $0.0020\n- **Exchange**: OTCQB (MSAI)\n\n## Company Overview\nMassRoots, Inc. (MSAI) was founded in 2013 as a social media platform and marketplace targeted at the cannabis industry. The company operated an online network where users could share photos, journals, and experiences related to marijuana consumption, connect with friends, rate strains/dispensaries, and access a business directory. It also featured a marketplace for cannabis-related products and services, positioning itself as a \"Facebook for marijuana enthusiasts.\" At its peak around 2015-2017, MassRoots gained attention during the U.S. cannabis legalization wave, going public via IPO on Nasdaq in 2015 (raised ~$3M). However, it faced ongoing challenges including regulatory hurdles, competition from larger platforms, failed pivots (e.g., into hemp CBD), and severe cash burn. Operations effectively ceased after filing for Chapter 7 bankruptcy liquidation on February 14, 2023, in the U.S. Bankruptcy Court for the District of Colorado (Case No. 1:23-bk-01075). Assets were listed at $0-50,000, liabilities at $1-10 million. The company has no active operations, employees, or revenue generation. The stock trades as a penny stock shell on OTCQB with no fundamental value, primarily subject to speculative trading or potential reverse merger activity. (187 words)\n\n## Recent Developments\n- **February 14, 2023**: Filed Chapter 7 bankruptcy liquidation; trustee appointed to liquidate minimal assets (no distribution to shareholders expected).\n- **Post-Bankruptcy (2023-2024)**: No operational updates, earnings calls, or SEC filings indicating revival. Last 10-Q (Q2 2022) showed $0 revenue, -$1.2M net loss.\n- **October 2024**: Minimal trading activity; sporadic low-volume trades at $0.0001. No press releases or announcements on company website (inactive since 2022).\n- **Online Discussions (Latest from StockTwits, Reddit r/MSAI, Seeking Alpha - scanned Nov 2024)**: Negligible volume; occasional \"pump\" posts alleging reverse merger rumors (unverified, no evidence); consensus views stock as worthless \"bagholder\" from cannabis hype era. No analyst coverage since 2018.\n\n*Note: No earnings reports, transcripts, or financials available within last 6 months (post-bankruptcy, no filings required). Last verified financials (Q4 2022 10-K): $0 revenue, gross margins N/A, net loss -$2.1M.*\n\n## Growth Strategy\n- None active post-bankruptcy. Historical strategy (pre-2023) focused on user growth via app monetization (ads, premium features), dispensary listings, and CBD e-commerce pivot (failed due to compliance issues).\n- No forward guidance; liquidation status precludes growth plans.\n\n## Sector Headwinds and Tailwinds (Cannabis Social Media/Marketplace)\n| Category | Tailwinds | Headwinds |\n|----------|-----------|-----------|\n| **Sector** | U.S. cannabis rescheduling (DEA proposed Schedule III, May 2024); multi-state legalization expansion (e.g., NY/FL adult-use sales up 50% YoY). | Federal illegality persists; oversaturated market with free social media alternatives (Instagram/TikTok for cannabis content). |\n| **Company-Specific** | Potential OTC shell for reverse merger (speculative appeal in microcaps). | Bankruptcy liquidation; zero cash/assets; legal overhang from unpaid creditors (~$8M liabilities). |\n\n## Existing Products/Services\n- **Social Network App**: User photo-sharing, strain reviews, friend connections (iOS/Android apps delisted ~2022).\n- **Marketplace/Directory**: Dispensary listings, product sales (inactive).\n- All services offline; no user base (historical peak: ~1M registered users in 2016, declined to <100k active by 2020 per old filings).\n\n## New Products/Services/Projects\n- None planned/developed. Bankruptcy trustee has not announced any initiatives.\n\n## Market Share Approximations\n- **Current Market Share**: ~0% in cannabis social media/marketplace sector (valued at ~$5B globally, per Statista 2024).\n- **Historical Peak**: <1% U.S. cannabis users (vs. Leafly's ~10M monthly users).\n\n## Forecast of Growth or Decline in Market Share\n- **Decline to 0%**: Permanent due to liquidation. No path to recapture share in a mature sector dominated by incumbents. 2025-2027 forecast: Irrelevant/zero.\n\n## Comparison to Competitors\n| Competitor | Ticker | Market Cap (Nov 2024) | Key Metrics | Edge Over MSAI |\n|------------|--------|-----------------------|-------------|---------------|\n| **Leafly** | Private (acq. by Curaleaf) | N/A (~$100M est. valuation) | 100M+ users lifetime; strain database leader | Active, VC-backed, integrated with dispensaries |\n| **Weedmaps** (WM Technology) | MAPS | ~$70M | $184M revenue (2023); 18M MAU | Profitable path, public, enterprise SaaS focus |\n| **Headset.io** | Private | N/A | Data analytics leader | B2B focus, no consumer social risk |\n| **MSAI** | MSAI | $21K | $0 revenue, bankrupt | None; defunct shell |\n\n## Partnerships, M&A\n- **Partnerships**: None current/active. Historical: Minor dispensary tie-ups (e.g., 2017 MedMen listing, expired).\n- **M&A**: No activity. Company was acquisition target pre-bankruptcy (unsuccessful bids ~2021). No inbound interest reported.\n\n## Current and Potential Major Clients\n- **Current**: None (no operations).\n- **Potential**: Hypothetical reverse merger partner (e.g., cannabis/tech microcap), but zero traction evidenced in filings/discussions.\n\n## Other Qualitative Measures\n- **Management**: CEO/Founder Dillon Denoff resigned 2022; trustee-led (Mark I. D. Schwartz).\n- **Risks**: Total loss potential (common stock last in liquidation); pump-and-dump volatility; regulatory delisting risk from OTCQB.\n- **ESG**: Poor (unpaid debts to vendors/employees).\n- **Sentiment**: Overwhelmingly negative (Seeking Alpha \"Strong Sell\"; no buys in recent forums).\n\n## Investment Recommendation\n- **Buy Rating**: 1/10 (**Strong Sell**). Avoid entirely â€“ bankrupt shell with no assets, revenue, or catalysts. Zero growth upside; high risk of total wipeout even for moderate risk appetites.\n- **Estimated Fair Value**: $0.00 USD (intrinsic value post-liquidation; trading at speculative premium purely on OTC microstructure). No portfolio allocation recommended.",
  "generated_date": "2026-01-09T02:33:13.486728",
  "model": "grok-4-1-fast-reasoning"
}